Clinical trial
Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State
NCT02223065
Study timeline
Study start (unknown)2014-09-01Date precision: month
Registry last updated2016-04-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Interventions
SaxagliptinDRUG · verified · RxNorm: saxagliptin
DapagliflozinDRUG · verified · RxNorm: dapagliflozin
Sponsors & collaborators
AstraZenecalead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02223065 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.